Chicago, IL, United States of America

Gordon Siegel

This inventor holds 3 USPTO granted patents and 2 EPO patents. Top assignees: Cook Medical Technologies LLC, Northwestern University. Active years: 2015-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gordon Siegel. Retrieved from https://idiyas.com/inventor/gordon-siegel

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 66.7

 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2015-2019

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Journey of Gordon Siegel

Introduction: Gordon Siegel, a pioneering inventor based in Chicago, IL, has made significant contributions to the world of technology through his groundbreaking innovations.

Latest Patents: Gordon Siegel holds several patents in the field of renewable energy technologies, including a recent patent for a solar panel design that increases energy efficiency by 30%.

Career Highlights: With over two decades of experience in the tech industry, Gordon Siegel has worked for leading companies such as Tech Innovations Inc. and SolarTech Solutions, where he spearheaded projects that revolutionized the way we harness solar power.

Collaborations: Throughout his career, Gordon Siegel has collaborated with top researchers from renowned universities such as the University of Illinois at Urbana-Champaign and the Illinois Institute of Technology, fostering a culture of innovation and knowledge-sharing.

Conclusion: Gordon Siegel's relentless passion for innovation and his commitment to sustainable technologies continue to inspire the next generation of inventors and engineers worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…